View on Pubmed.gov 27554530 | View on doi.org 10.1016/j.neuro...
Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans.
- School of Physiology, Pharmacology & Neuroscience, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, United Kingdom; Department of Neurosurgery & Pain Medicine, North Bristol NHS Trust, Bristol BS10 5NB, United Kingdom.
- Imaging Sciences, MAHSC, University of Manchester, M20 3LJ, United Kingdom.
- Department of Neurosurgery & Pain Medicine, North Bristol NHS Trust, Bristol BS10 5NB, United Kingdom.
- Clinical Research Imaging Centre (CRiCBristol), University of Bristol, Bristol BS2 8DZ, United Kingdom.
- School of Physiology, Pharmacology & Neuroscience, Medical Sciences Building, University of Bristol, Bristol BS8 1TD, United Kingdom; Department of Anaesthesia, University Hospitals Bristol, Bristol BS2 8HW, United Kingdom. Electronic address: Tony.Pickering@Bristol.ac.uk.
Abstract
Deep brain stimulation (DBS) of the periaqueductal gray (PAG) is used in the treatment of severe refractory neuropathic pain. We tested the hypothesis that DBS releases endogenous opioids to exert its analgesic effect using [ 11C]diprenorphine (DPN) positron emission tomography (PET). Patients with de-afferentation pain (phantom limb pain or Anaesthesia Dolorosa (n=5)) who obtained long-lasting analgesic benefit from DBS were recruited. [ 11C]DPN and [ 15O]water PET scanning was performed in consecutive sessions; first without, and then with PAG stimulation. The regional cerebral tracer distribution and kinetics were quantified for the whole brain and brainstem. Analysis was performed on a voxel-wise basis using statistical parametric mapping (SPM) and also within brainstem regions of interest and correlated to the DBS-induced improvement in pain score and mood. Brain-wide analysis identified a single cluster of reduced [ 11C]DPN binding (15.5% reduction) in the caudal, dorsal PAG following DBS from effective electrodes located in rostral dorsal/lateral PAG. There was no evidence for an accompanying focal change in blood flow within the PAG. No correlation was found between the change in PAG [ 11C]DPN binding and the analgesic effect or the effect on mood (POMS SV) of DBS. The analgesic effect of DBS in these subjects was not altered by systemic administration of the opioid antagonist naloxone (400ug). These findings indicate that DBS of the PAG does indeed release endogenous opioid peptides focally within the midbrain of these neuropathic pain patients but we are unable to further resolve the question of whether this release is responsible for the observed analgesic benefit.
References
Eur J Pharmacol. 2003 Jan 17;459(2-3):217-9
Pain. 2007 Jan;127(1-2):183-94
Exp Physiol. 2002 Mar;87(2):281-6
J Nucl Med. 2010 Nov;51(11):1732-9
Cited by 66 citations (total)
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review
Challenges and opportunities for brainstem neuroimaging with ultrahigh field MRI.
Electronic publication date December 12, 2018
Roberta Sclocco [...] Vitaly Napadow et al.
The human brainstem plays a central role in connecting the cerebrum, the cerebellum and the spinal cord to one another,...
Journal Article
Swearing as a Response to Pain: Assessing Hypoalgesic Effects of Novel "Swear" Words.
Electronic publication date May 20, 2020
Richard Stephens [...] Olly Robertson et al.
Previous research showing that swearing alleviates pain is extended by addressing emotion arousal and distraction as possible mechanisms. We assessed...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
Substances
- •
- •
- •
Copyright
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.